Wiltrom Co., Ltd. (TPEX:6767)
21.60
-0.90 (-4.00%)
Nov 20, 2026, 1:04 PM CST
Wiltrom Revenue
Wiltrom had revenue of 83.23M TWD in the quarter ending September 30, 2026, with 0.03% growth. This brings the company's total for the last twelve months to 314.12M, down -7.17% year-over-year. In the year 2025, Wiltrom had annual revenue of 311.77M, down -6.86%. That makes Wiltrom the 37,640th largest company in the world by revenue and 1,966th in Taiwan.
Revenue (ttm)
314.12M
Revenue Growth
-7.17%
P/S Ratio
2.69
Revenue / Employee
n/a
Employees
n/a
Market Cap
846.37M
Revenue by Geography
- Asia 291.32M 93.4%
- The Americas 12.61M 4.0%
- Europe 7.70M 2.5%
- Africa 141.00K 0.0%
Fiscal year ended Dec 31, 2025 See the full Wiltrom breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 311.77M | -22.96M | -6.86% |
| Dec 31, 2024 | 334.73M | 57.62M | 20.79% |
| Dec 31, 2023 | 277.11M | 70.25M | 33.96% |
| Dec 31, 2022 | 206.86M | 62.37M | 43.16% |
| Dec 31, 2021 | 144.50M | 42.13M | 41.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.82B |
| Cowealth Medical Holding | 2.95B |
| AViTA | 1.05B |
| Bioptik Technology Incorporation | 891.73M |
| Diamond Biotechnology | 464.63M |
| Radiant Innovation | 417.97M |
| S&S Healthcare Holding | 185.52M |
| Taiwan Biomaterial | 153.37M |